As AI disrupts the world, Brisbane tech leader joins up with Bain & Co
Brisbane-based machine learning and artificial intelligence company Max Kelsen has been sold to Bain & Company for an undisclosed sum.
Bain announced that it had acquired Max Kelsen’s consulting and managed services divisions (collectively referred to as “Max Kelsen Consulting”).
Founded in 2015, Max Kelsen has been at the forefront of Brisbane’s growth in new technology industries and played a role in forecasting the impacts of Covid.
Bain’s global head of advanced analytics Roy Singh said the acquisition would help Bain deliver to enterprises high-impact AI and ML-enabled uses.
“We are delighted to welcome the Max Kelsen Consulting team to Bain, and to bring their industry-leading machine learning expertise to bear to deliver even more powerful solutions to our clients,” Singh said.
“We are seeing growing demand from clients for AI-related services and engineering capabilities that will enable them to be early movers in shaping how this generational shift in technology could transform their respective industries.”
Max Kelsen has built and deployed ML solutions including real-time prediction, forecasting, computer vision, industrial control optimization, robotics and more.
While Max Kelsen applies its ML and AI expertise across industries, such as mining, financial services and retail, the company has particularly deep experience serving the healthcare & life sciences sector.
Co-founder and chief executive of Max Kelsen, Nicholas Therkelsen-Terry, said the company was excited to join Bain at a time when businesses were starting to navigate the disruptions brought on by generative AI.
“In a rapidly evolving business climate, companies that understand how to use these tools to their advantage will come out on top. By joining Bain, we are thrilled to be working with an even larger pool of global clients and supporting Bain to strengthen their global ML capabilities,” he said
Max Kelsen also operates a products division (SAVI Surgical and PROPeL Health AI) and a research division, which are not part of the acquisition by Bain.
The Max Kelsen team was expected to remain in Brisbane.
